| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Common Stock | Options Exercise | $254,562 | +6,270 | +10% | $40.60 | 67,365 | 15 Nov 2022 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $400,821 | -4,744 | -7% | $84.49 | 62,621 | 15 Nov 2022 | Direct | F1 |
| transaction | TMP | Common Stock | Options Exercise | $370,627 | +7,530 | +12% | $49.22 | 70,151 | 15 Nov 2022 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $511,756 | -6,057 | -8.6% | $84.49 | 64,094 | 15 Nov 2022 | Direct | F1 |
| transaction | TMP | Common Stock | Options Exercise | $272,162 | +4,835 | +7.5% | $56.29 | 68,929 | 15 Nov 2022 | Direct | |
| transaction | TMP | Common Stock | Tax liability | $344,635 | -4,079 | -5.9% | $84.49 | 64,850 | 15 Nov 2022 | Direct | F2 |
| holding | TMP | Common Stock | 9,962 | 15 Nov 2022 | by 401(k)/ISOP | ||||||
| holding | TMP | Common Stock | 5,055 | 15 Nov 2022 | by ESOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -6,270 | -100% | $0.000000* | 0 | 15 Nov 2022 | Common Stock | 6,270 | $40.60 | Direct | F3 |
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -7,530 | -100% | $0.000000* | 0 | 15 Nov 2022 | Common Stock | 7,530 | $49.22 | Direct | F3 |
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -4,835 | -100% | $0.000000* | 0 | 15 Nov 2022 | Common Stock | 4,835 | $56.29 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Shares withheld for option cost and taxes. |
| F2 | Shares withheld for option cost and taxes. |
| F3 | Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant. |